| Literature DB >> 24010909 |
Abstract
This article presents an overview of positron emission tomography combined with computed tomography (PET/CT) imaging of bone tumors for the practicing radiologist. The clinical roles and utility of (18)F-labeled fluorodeoxyglucose PET/CT in patients with primary bone tumors, osseous metastases, and multiple myeloma are reviewed. The clinical and research data supporting the utility of PET/CT in the evaluation of skeletal malignancies continues to grow.Entities:
Keywords: Bony metastasis; Fluorodeoxyglucose; Multiple myeloma; Osteosarcoma; PET/CT; Positron emission tomography
Mesh:
Substances:
Year: 2013 PMID: 24010909 DOI: 10.1016/j.rcl.2013.05.005
Source DB: PubMed Journal: Radiol Clin North Am ISSN: 0033-8389 Impact factor: 2.303